Login to Your Account

ZymoGenetics Skyrockets 84% on $885M BMS Offer

By Donna Young

Thursday, September 9, 2010
ZymoGenetics Inc. is the latest treasure Bristol-Myers Squibb Co. is seeking to add its string of pearls under the pharma giant's 2007 strategy to grow its R&D pipeline, offering $9.75 per share for the Seattle biotech, or about $885 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription